Medicube Pink Peptide Serum: 2026 Multi-Peptide Anti-Aging Efficacy Data & Industry Growth Forecast
Abstract Medicube Pink Peptide Serum leverages a multi-peptide complex (including copper tripeptide-1, palmitoyl pentapeptide-4) to target collagen synthesis and skin barrier repair. 2026 efficacy data from a 12-week clinical trial (n 120) shows a 34% reduction in fine lines and 28% improvement in elasticity. The global peptide skincare market is projected to grow at a CAGR of 7.8% through 2030, driven by aging demographics and demand for evidence-based anti-aging solutions. Compared to retinol-based alternatives, this serum offers lower irritation with comparable wrinkle reduction. Selection guide: ideal for sensitive, aging skin seeking non-irritating multi-targeted repair. Industry insight: peptide stability and delivery systems remain key differentiators in product efficacy.